MDxHealth is trading 6.37% up at $0.17 after the November 2 regular-session close at $0.16; no specific after-hours catalyst was identified. - Price context shows a modest rebound after several declining sessions. - The latest company announcement, dated October 29, said third-quarter results are due November 12; it does not explain the rise. An earlier preliminary revenue shortfall and suspension of full-year guidance are background, not a clear explanation.